Philadelphia, PA, United States of America

Joseph A Finkelstein


Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 69(Granted Patents)


Location History:

  • US (1994)
  • Philadelphia, PA (US) (1986 - 1995)

Company Filing History:


Years Active: 1986-1995

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Joseph A. Finkelstein

Introduction

Joseph A. Finkelstein, based in Philadelphia, PA, is a prominent inventor known for his significant contributions in the field of pharmaceuticals. With a remarkable portfolio of 11 patents, Finkelstein has made noteworthy advancements, particularly in the area of angiotensin II receptor antagonists, which play a critical role in regulating hypertension and treating various heart conditions.

Latest Patents

Finkelstein's latest innovations include two pivotal patents focused on imidazolyl-alkenoic acids and substituted imidazoles. His patent on imidazolyl-alkenoic acids emphasizes their utility as angiotensin II receptor antagonists, which are essential not only in regulating hypertension but also in treating congestive heart failure, renal failure, and glaucoma. This patent outlines pharmaceutical compositions that incorporate these antagonists alongside methods for their application in producing angiotensin II receptor antagonism in mammals. Similarly, his patent for substituted imidazoles details their angiotensin II receptor blocking activity, thereby further enhancing our understanding and treatment capability for related medical conditions.

Career Highlights

Throughout his career, Finkelstein has been associated with reputable organizations, including SmithKline Beckman Corporation and SmithKline Beecham Corporation. His work with these companies has allowed him to leverage his expertise to develop innovative pharmaceutical solutions that address significant health concerns.

Collaborations

Finkelstein has collaborated with numerous professionals in his field. Notable among his coworkers are Lawrence I. Kruse and Thomas B. Leonard, with whom he has shared insights and strategies that propelled their research and development efforts forward.

Conclusion

Joseph A. Finkelstein stands as a significant figure in the realm of pharmaceutical innovation, with a well-documented history of advancements that greatly enhance the treatment of hypertension and related health issues. His contributions as an inventor reflect a dedicated pursuit of knowledge and improvement in pharmaceutical practices, solidifying his role as a notable innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…